Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015;36(5):487–525. https://doi.org/10.1210/er.2015-1018.
Alesi S, Ee C, Moran LJ. Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome. 2022;13(4):1243–66. https://doi.org/10.1093/advances/nmab141.
Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668–80. https://doi.org/10.1016/s2213-8587(22)00163-2.
Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta. 2017;1863(5):1037–45. https://doi.org/10.1016/j.bbadis.2016.04.017.
Mancini A, Bruno C, Vergani E, d’Abate C, Giacchi E, Silvestrini A. Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights. 2021;22(4). https://doi.org/10.3390/ijms22041667.
Liu S, Jia Y, Meng S, Luo Y, Yang Q, Pan Z. Mechanisms of and Potential Medications for Oxidative Stress in Ovarian Granulosa Cells: A Review. 2023;24(11). https://doi.org/10.3390/ijms24119205.
Yan F, Zhao Q, Li Y, Zheng Z, Kong X, Shu C, et al. The role of oxidative stress in ovarian aging: a review. Journal of ovarian research. 2022;15(1):100. https://doi.org/10.1186/s13048-022-01032-x.
Guo F, Gong Z, Fernando T, Zhang L, Zhu X, Shi Y. The Lipid Profiles in Different Characteristics of Women with PCOS and the Interaction Between Dyslipidemia and Metabolic Disorder States: A Retrospective Study in Chinese Population. Front Endocrinol. 2022;13:892125. https://doi.org/10.3389/fendo.2022.892125.
Paoli A, Mancin L, Giacona MC, Bianco A, Caprio M. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome. J Transl Med. 2020;18(1):104. https://doi.org/10.1186/s12967-020-02277-0.
Elmugadam A, Elfadil GA. Atherogenic Index of Plasma and Anthropometric Measurements among Osteoporotic Postmenopausal Sudanese Women: Possible Risk for Cardiovascular Disease. 2022;2022:1545127. https://doi.org/10.1155/2022/1545127.
Parveen S, Khan S, Khan MM, Gupta B, Ahmad A, Alam R. Association of lipid profile and obesity in patients with polycystic ovary syndrome. Endocr Regul. 2024;58(1):83–90. https://doi.org/10.2478/enr-2024-0009.
Cruz-Gregorio A, Aranda-Rivera AK, Ortega-Lozano AJ, Pedraza-Chaverri J, Mendoza-Hoffmann F. Lipid metabolism and oxidative stress in HPV-related cancers. Free Radical Biol Med. 2021;172:226–36. https://doi.org/10.1016/j.freeradbiomed.2021.06.009.
Chakraborty S, Datta S, Datta S. Surrogate variable analysis using partial least squares (SVA-PLS) in gene expression studies. Bioinformatics (Oxford, England). 2012;28(6):799–806. https://doi.org/10.1093/bioinformatics/bts022.
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–50. https://doi.org/10.1073/pnas.0506580102.
Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Current protocols in bioinformatics. 2016;54:1.30.1–1..3. https://doi.org/10.1002/cpbi.5.
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https://doi.org/10.1093/nar/gkv007.
Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. Methods in molecular biology (Clifton, NJ). 2018;1711:243–59. https://doi.org/10.1007/978-1-4939-7493-1_12.
Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics (Oxford, England). 2010;26(12):1572–3. https://doi.org/10.1093/bioinformatics/btq170.
Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559. https://doi.org/10.1186/1471-2105-9-559.
Sato N, Tamada Y, Yu G. CBNplot: Bayesian network plots for enrichment analysis. 2022;38(10):2959–60. https://doi.org/10.1093/bioinformatics/btac175.
Yoo M, Shin J, Kim J, Ryall KA, Lee K, Lee S, et al. DSigDB: drug signatures database for gene set analysis. Bioinformatics (Oxford, England). 2015;31(18):3069–71. https://doi.org/10.1093/bioinformatics/btv313.
Poojary PS, Nayak G, Panchanan G, Rao A, Kundapur SD, Kalthur SG, et al. Distinctions in PCOS Induced by Letrozole Vs Dehydroepiandrosterone With High-fat Diet in Mouse Model. 2022;163(9). https://doi.org/10.1210/endocr/bqac097.
Xiao N, Wang J, Wang T, Xiong X, Zhou J, Su X, et al. Metformin abrogates pathological TNF-α-producing B cells through mTOR-dependent metabolic reprogramming in polycystic ovary syndrome. 2022;11. https://doi.org/10.7554/eLife.74713.
Xiao J, Shen K, Liu K, Wang Y, Fan H, Cheng Q, et al. Obesity promotes lipid accumulation in lymph node metastasis of gastric cancer: a retrospective case-control study. Lipids Health Dis. 2022;21(1):123. https://doi.org/10.1186/s12944-022-01734-7.
Wang J, Yin T, Liu S. Dysregulation of immune response in PCOS organ system. Front Immunol. 2023;14:1169232. https://doi.org/10.3389/fimmu.2023.1169232.
Guixue G, Yifu P, Yuan G, Xialei L, Fan S, Qian S, et al. Progress of the application clinical prediction model in polycystic ovary syndrome. Journal of ovarian research. 2023;16(1):230. https://doi.org/10.1186/s13048-023-01310-2.
Goutami L, Jena SR, Swain A, Samanta L. Pathological Role of Reactive Oxygen Species on Female Reproduction. Adv Exp Med Biol. 2022;1391:201–20. https://doi.org/10.1007/978-3-031-12966-7_12.
Macut D, Bjekić-Macut J, Savić-Radojević A. Dyslipidemia and oxidative stress in PCOS. Front Horm Res. 2013;40:51–63. https://doi.org/10.1159/000341683.
Naigaonkar A, Dadachanji R. Altered redox status may contribute to aberrant folliculogenesis and poor reproductive outcomes in women with polycystic ovary syndrome. 2021;38(10):2609–23. https://doi.org/10.1007/s10815-021-02241-x.
Liu Y, Liu H, Li Z, Fan H, Yan X, Liu X, et al. The Release of Peripheral Immune Inflammatory Cytokines Promote an Inflammatory Cascade in PCOS Patients via Altering the Follicular Microenvironment. Front Immunol. 2021;12:685724. https://doi.org/10.3389/fimmu.2021.685724.
Velez LM, Seldin M, Motta AB. Inflammation and reproductive function in women with polycystic ovary syndrome†. Biol Reprod. 2021;104(6):1205–17. https://doi.org/10.1093/biolre/ioab050.
Yang L, Chen Y, Liu Y, Xing Y, Miao C, Zhao Y, et al. The role of oxidative stress and natural antioxidants in ovarian aging. Front Pharmacol. 2020;11:617843. https://doi.org/10.3389/fphar.2020.617843.
Liang J, Gao Y, Feng Z, Zhang B, Na Z, Li D. Reactive oxygen species and ovarian diseases: Antioxidant strategies. Redox Biol. 2023;62:102659. https://doi.org/10.1016/j.redox.2023.102659.
Artimani T, Karimi J, Mehdizadeh M, Yavangi M, Khanlarzadeh E, Ghorbani M, et al. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS). Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2018;34(2):148–52. https://doi.org/10.1080/09513590.2017.1371691.
Żelechowska P, Agier J, Kozłowska E, Brzezińska-Błaszczyk E. Mast cells participate in chronic low-grade inflammation within adipose tissue. 2018;19(5):686–97. https://doi.org/10.1111/obr.12670.
Yilmaz MA, Duran C, Basaran M. The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome. J Endocrinol Invest. 2016;39(1):45–53. https://doi.org/10.1007/s40618-015-0335-2.
Pergialiotis V, Trakakis E, Parthenis C, Hatziagelaki E, Chrelias C, Thomakos N, et al. Correlation of platelet to lymphocyte and neutrophil to lymphocyte ratio with hormonal and metabolic parameters in women with PCOS. Hormone molecular biology and clinical investigation. 2018;34(3). https://doi.org/10.1515/hmbci-2017-0073.
Chapman JC, Min SH, Freeh SM, Michael SD. The estrogen-injected female mouse: new insight into the etiology of PCOS. Reproductive biology and endocrinology : RB&E. 2009;7:47. https://doi.org/10.1186/1477-7827-7-47.
Luan YY, Zhang L, Peng YQ, Li YY, Liu RX, Yin CH. Immune regulation in polycystic ovary syndrome. Clinica chimica acta; international journal of clinical chemistry. 2022;531:265–72. https://doi.org/10.1016/j.cca.2022.04.234.
Xiao H, Yin T. Association between immunity and different clinical symptoms in patients with polycystic ovary syndrome. 2023;90(4):e13780. https://doi.org/10.1111/aji.13780.
Shen P, Fillatreau S. Antibody-independent functions of B cells: a focus on cytokines. Nat Rev Immunol. 2015;15(7):441–51. https://doi.org/10.1038/nri3857.
Menard LC, Minns LA, Darche S, Mielcarz DW, Foureau DM, Roos D, et al. B cells amplify IFN-gamma production by T cells via a TNF-alpha-mediated mechanism. Journal of immunology (Baltimore, Md : 1950). 2007;179(7):4857–66. https://doi.org/10.4049/jimmunol.179.7.4857.
Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010;72:219–46. https://doi.org/10.1146/annurev-physiol-021909-135846.
Bruno MEC, Mukherjee S, Powell WL, Mori SF, Wallace FK, Balasuriya BK, et al. Accumulation of γδ T cells in visceral fat with aging promotes chronic inflammation. 2022;44(3):1761–78. https://doi.org/10.1007/s11357-022-00572-w.
Karakose M, Demircan K, Tutal E, Demirci T, Arslan MS, Sahin M, et al. Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome. J Endocrinol Invest. 2016;39(11):1269–75. https://doi.org/10.1007/s40618-016-0472-2.
Lång P, Patlaka C, Andersson G. Tartrate-resistant acid phosphatase type 5/ACP5 promotes cell cycle entry of 3T3-L1 preadipocytes by increasing IGF-1/Akt signaling. FEBS Lett. 2021;595(20):2616–27. https://doi.org/10.1002/1873-3468.14184.
Lång P, van Harmelen V, Rydén M, Kaaman M, Parini P, Carneheim C, et al. Monomeric tartrate resistant acid phosphatase induces insulin sensitive obesity. PLoS ONE. 2008;3(3):e1713. https://doi.org/10.1371/journal.pone.0001713.
Bassez A, Vos H, Van Dyck L, Floris G. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. 2021;27(5):820–32. https://doi.org/10.1038/s41591-021-01323-8.
Zhou W, Gao F. Single-cell deletion analyses show control of pro-T cell developmental speed and pathways by Tcf7, Spi1, Gata3, Bcl11a, Erg, and Bcl11b. 2022;7(71):eabm1920. https://doi.org/10.1126/sciimmunol.abm1920.
Ramos-Lopez O, Riezu-Boj JI, Milagro FI. Association of Methylation Signatures at Hepatocellular Carcinoma Pathway Genes with Adiposity and Insulin Resistance Phenotypes. 2019;71(5):840–51. https://doi.org/10.1080/01635581.2018.1531136.
Campbell JE, Ussher JR, Mulvihill EE, Kolic J, Baggio LL, Cao X, et al. TCF1 links GIPR signaling to the control of beta cell function and survival. Nat Med. 2016;22(1):84–90. https://doi.org/10.1038/nm.3997.
Schmitter T, Agerer F, Peterson L, Munzner P, Hauck CR. Granulocyte CEACAM3 is a phagocytic receptor of the innate immune system that mediates recognition and elimination of human-specific pathogens. J Exp Med. 2004;199(1):35–46. https://doi.org/10.1084/jem.20030204.
Buntru A, Kopp K, Voges M, Frank R, Bachmann V, Hauck CR. Phosphatidylinositol 3’-kinase activity is critical for initiating the oxidative burst and bacterial destruction during CEACAM3-mediated phagocytosis. J Biol Chem. 2011;286(11):9555–66. https://doi.org/10.1074/jbc.M110.216085.
Chen H, Wang J, Zhang C, Ding P, Tian S, Chen J, et al. Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022;153:113341. https://doi.org/10.1016/j.biopha.2022.113341.
Cartier A, Hla T. Sphingosine 1-phosphate: Lipid signaling in pathology and therapy. 2019;366(6463). https://doi.org/10.1126/science.aar5551.
Hong CH, Ko MS, Kim JH, Cho H, Lee CH, Yoon JE, et al. Sphingosine 1-Phosphate Receptor 4 Promotes Nonalcoholic Steatohepatitis by Activating NLRP3 Inflammasome. Cell Mol Gastroenterol Hepatol. 2022;13(3):925–47. https://doi.org/10.1016/j.jcmgh.2021.12.002.
Castelli V, Brandolini L, d’Angelo M. CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling. 2021;10(9). https://doi.org/10.3390/cells10092324.
Citro A, Cantarelli E, Maffi P, Nano R, Melzi R, Mercalli A, et al. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation. J Clin Investig. 2012;122(10):3647–51. https://doi.org/10.1172/jci63089.
Banaszewska B, Ozegowska K, Polska M, Pawelczyk L. Ibuprofen Reduces Testosterone Level in Women With Polycystic Ovary Syndrome. 2022;6(10):bvac128. https://doi.org/10.1210/jendso/bvac128.
Hu X, Cifarelli V, Sun S, Kuda O, Abumrad NA, Su X. Major role of adipocyte prostaglandin E2 in lipolysis-induced macrophage recruitment. J Lipid Res. 2016;57(4):663–73. https://doi.org/10.1194/jlr.M066530.
Arroll B. Non-antibiotic treatments for upper-respiratory tract infections (common cold). Respir Med. 2005;99(12):1477–84. https://doi.org/10.1016/j.rmed.2005.09.039.
Chen H, Xu H, Luo L, Qiao L, Wang Y, Xu M, et al. Thalidomide Prevented and Ameliorated Pathogenesis of Crohn’s Disease in Mice via Regulation of Inflammatory Response and Fibrosis. Front Pharmacol. 2019;10:1486. https://doi.org/10.3389/fphar.2019.01486.
Add Comment